New drugs are available for early-onset Alzheimer’s, psoriasis, migraine and ADHD.

It is estimated that at least nine per cent of overall prescription spending in many group plans can be attributed to th…

Insurers should consider the implications of a wider deployment of these drugs for treating a much broader range of dise…

Costly new drugs are proliferating.

Insurer’s data shows claims for diabetes and high blood pressure among young women are significantly out pacing claims m…

Patented medicines make up approximately 47 per cent of all drug sales in Canada.

Healthcare spending could rise to $9,054 per capita.